<p>Geode Capital Management LLC 在最近向證券交易委員會（SEC）提交的文件中表示，在第四季度將其在 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的股份增加了 2.5%。該基金在此期間購買了額外的 116,430 股後，持有該公司 4,798,313 股股票。截至其最近的 SEC 文件，Geode Capital Management LLC 持有 Oscar Health 1.81% 的股份，價值 68,964,000 美元。</p>
<ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
<p>其他幾家機構投資者和對沖基金也對 OSCR 的持倉進行了調整。美國世紀公司在第三季度將其在 Oscar Health 的持股增加了 89.0%。美國世紀公司現在持有 5,298,340 股該公司的股票，價值 100,298,000 美元，此前在上個季度購買了額外的 2,495,691 股。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 現在持有 3,639,000 股該公司的股票，價值 68,886,000 美元，此前在上個季度購買了額外的 2,163,000 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持倉提高了 33.4%。Thrive Capital Management LLC 現在持有 6,343,617 股該公司的股票，價值 85,258,000 美元，此前在此期間購買了額外的 1,588,395 股。Marshall Wace LLP 在第三季度將其在 Oscar Health 的持倉提高了 3,796.6%。Marshall Wace LLP 現在持有 1,137,839 股該公司的股票，價值 21,539,000 美元，此前在此期間購買了額外的 1,108,638 股。最後，Fred Alger Management LLC 在第三季度將其在 Oscar Health 的持倉提高了 225.6%。Fred Alger Management LLC 現在持有 1,212,383 股該公司的股票，價值 22,950,000 美元，此前在此期間購買了額外的 840,038 股。目前，75.70% 的股票由機構投資者和對沖基金持有。</p>
<h2>Oscar Health 股票表現</h2>
<p>紐約證券交易所代碼：OSCR 週二開盤價為 27.37 美元。該公司的 50 日簡單移動平均線為 18.70 美元，200 日簡單移動平均線為 16.16 美元。該公司的市值為 82.5 億美元，市盈率為 -46.39，市盈增長比率為 1.71，貝塔值為 2.37。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。Oscar Health, Inc. 的 52 周最低價為 10.69 美元，52 周最高價為 27.59 美元。</p>
<p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 5 月 6 日星期三發佈了季度財報。該公司報告季度每股收益為 2.07 美元，超出市場共識預期的 1.11 美元，差額為 0.96 美元。該業務在本季度的收入為 46.5 億美元，而市場共識預期為 49 億美元。Oscar Health 的淨利潤率為 -0.30%，股本回報率為 -3.26%。該公司的季度收入較去年同期增長了 52.6%。在去年同期，該公司每股收益為 0.92 美元。整體來看，股票分析師預計 Oscar Health, Inc. 在本財年將發佈 0.47 美元的每股收益。</p>
<h2>華爾街分析師預測增長</h2>
<p>幾家研究公司最近對 OSCR 發表了評論。Zacks Research 在 5 月 7 日的研究報告中將 Oscar Health 的股票評級從 “持有” 上調至 “強力買入”。Raymond James Financial 在 2 月 12 日的研究報告中將 Oscar Health 的股票評級從 “市場表現” 上調至 “跑贏大盤”，並設定了 18.00 美元的目標價。Wall Street Zen 在一份研究報告中將 Oscar Health 的股票評級從 “強力買入” 下調至 “買入”。富國銀行在一份研究報告中設定了 Oscar Health 的目標價為 20.00 美元，並給予該公司 “等權重” 評級。最後，瑞銀集團在 5 月 7 日的研究報告中將 Oscar Health 的目標價從 15.00 美元上調至 20.00 美元，並給予該公司 “中性” 評級。一位投資分析師對該股票給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 “持有”，共識目標價為 20.22 美元。</p>
<p><strong>查看我們最新的 OSCR 股票報告</strong></p>
<h2>內部人士下注</h2>
<p>在關於 Oscar Health 的其他消息中，內部人士 Adam Mcananey 於 6 月 2 日星期二出售了 9,859 股該公司的股票。股票的平均售價為 21.94 美元，總價值為 216,306.46 美元。交易完成後，該內部人士持有 218,096 股公司的股票，價值為 4,785,026.24 美元。這筆交易使其持股減少了 4.32%。該交易已在向 SEC 提交的法律文件中披露，相關信息可在 SEC 網站上查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售的目的是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。此外，董事 Mario Schlosser 於 6 月 2 日星期二出售了 34,120 股該公司的股票。股票的平均售價為 21.94 美元，總交易額為 748,592.80 美元。交易完成後，該董事持有 480,866 股公司的股票，價值約為 10,550,200.04 美元。這筆交易使其持股減少了 6.63%。該銷售的披露信息可在 SEC 文件中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售的目的是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去一個季度中，內部人士已出售 189,660 股公司股票，價值為 4,283,140 美元。公司內部人士持有 25.11% 的公司股票。</p>
<h2>Oscar Health 公司簡介</h2>
<p>（免費報告）</p>
<p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
<p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
<h2>推薦故事</h2>
<ul>
<li>我們更看好的五隻股票超過 Oscar Health</li>
<li>7 月 4 日之前需要關注的 3 只新催化劑股票</li>
<li>Amprius 內部人士正在出售：投資者應該擔心嗎？</li>
<li>較弱的美元可能使這 3 只工業股票重新受到關注</li>
<li>向優質股票的市場輪動將使這 3 只 ETF 受益</li>
</ul>
<p><strong>想看看其他對 OSCR 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（NYSE:OSCR - 免費報告）的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
<p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
<p>雖然 Oscar Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

OSCR

OSCG

OSCX

<p>Geode Capital Management LLC 在第四季度將其在 Oscar Health (NYSE:OSCR) 的持股增加了 2.5%，持有 480 萬股，價值 6896 萬美元。其他機構如 American Century 和 Farallon Capital 也增加了持股。Oscar Health 最近報告了第一季度每股收益為 2.07 美元，超出預期，收入為 46.5 億美元。分析師的評級意見不一，平均評級為 “持有”，共識目標價為 20.22 美元</p>

<p>Geode Capital Management LLC lifted its stake in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,798,313 shares of the company's stock after purchasing an additional 116,430 shares during the period. Geode Capital Management LLC owned 1.81% of Oscar Health worth $68,964,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Geode Capital Management LLC 在最近向證券交易委員會（SEC）提交的文件中表示，在第四季度將其在 Oscar Health, Inc.（紐約證券交易所代碼：OSCR - 免費報告）的股份增加了 2.5%。該基金在此期間購買了額外的 116,430 股後，持有該公司 4,798,313 股股票。截至其最近的 SEC 文件，Geode Capital Management LLC 持有 Oscar Health 1.81% 的股份，價值 68,964,000 美元。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上漲潛力的小型股</li>
</ul>
</div><p>Several other institutional investors and hedge funds have also made changes to their positions in OSCR. American Century Companies Inc. boosted its holdings in shares of Oscar Health by 89.0% during the 3rd quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after purchasing an additional 2,495,691 shares during the last quarter. Farallon Capital Management LLC boosted its holdings in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after purchasing an additional 2,163,000 shares during the last quarter. Thrive Capital Management LLC raised its position in shares of Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after buying an additional 1,588,395 shares during the period. Marshall Wace LLP raised its position in shares of Oscar Health by 3,796.6% during the 3rd quarter. Marshall Wace LLP now owns 1,137,839 shares of the company's stock valued at $21,539,000 after buying an additional 1,108,638 shares during the period. Finally, Fred Alger Management LLC raised its position in shares of Oscar Health by 225.6% during the 3rd quarter. Fred Alger Management LLC now owns 1,212,383 shares of the company's stock valued at $22,950,000 after buying an additional 840,038 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家機構投資者和對沖基金也對 OSCR 的持倉進行了調整。美國世紀公司在第三季度將其在 Oscar Health 的持股增加了 89.0%。美國世紀公司現在持有 5,298,340 股該公司的股票，價值 100,298,000 美元，此前在上個季度購買了額外的 2,495,691 股。Farallon Capital Management LLC 在第三季度將其在 Oscar Health 的持股增加了 146.5%。Farallon Capital Management LLC 現在持有 3,639,000 股該公司的股票，價值 68,886,000 美元，此前在上個季度購買了額外的 2,163,000 股。Thrive Capital Management LLC 在第四季度將其在 Oscar Health 的持倉提高了 33.4%。Thrive Capital Management LLC 現在持有 6,343,617 股該公司的股票，價值 85,258,000 美元，此前在此期間購買了額外的 1,588,395 股。Marshall Wace LLP 在第三季度將其在 Oscar Health 的持倉提高了 3,796.6%。Marshall Wace LLP 現在持有 1,137,839 股該公司的股票，價值 21,539,000 美元，此前在此期間購買了額外的 1,108,638 股。最後，Fred Alger Management LLC 在第三季度將其在 Oscar Health 的持倉提高了 225.6%。Fred Alger Management LLC 現在持有 1,212,383 股該公司的股票，價值 22,950,000 美元，此前在此期間購買了額外的 840,038 股。目前，75.70% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表現</h2>
</div><p>NYSE:OSCR opened at $27.37 on Tuesday. The company has a fifty day simple moving average of $18.70 and a two-hundred day simple moving average of $16.16. The company has a market cap of $8.25 billion, a price-to-earnings ratio of -46.39, a price-to-earnings-growth ratio of 1.71 and a beta of 2.37. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $10.69 and a 52 week high of $27.59.</p>
<div class="lb-trans"><p>紐約證券交易所代碼：OSCR 週二開盤價為 27.37 美元。該公司的 50 日簡單移動平均線為 18.70 美元，200 日簡單移動平均線為 16.16 美元。該公司的市值為 82.5 億美元，市盈率為 -46.39，市盈增長比率為 1.71，貝塔值為 2.37。該公司的速動比率為 1.11，流動比率為 1.11，債務與股本比率為 0.26。Oscar Health, Inc. 的 52 周最低價為 10.69 美元，52 周最高價為 27.59 美元。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The company's quarterly revenue was up 52.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 earnings per share. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Oscar Health（紐約證券交易所代碼：OSCR - 獲取免費報告）最近於 5 月 6 日星期三發佈了季度財報。該公司報告季度每股收益為 2.07 美元，超出市場共識預期的 1.11 美元，差額為 0.96 美元。該業務在本季度的收入為 46.5 億美元，而市場共識預期為 49 億美元。Oscar Health 的淨利潤率為 -0.30%，股本回報率為 -3.26%。該公司的季度收入較去年同期增長了 52.6%。在去年同期，該公司每股收益為 0.92 美元。整體來看，股票分析師預計 Oscar Health, Inc. 在本財年將發佈 0.47 美元的每股收益。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several research firms have recently commented on OSCR. Zacks Research raised shares of Oscar Health from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Thursday, May 7th. Raymond James Financial raised shares of Oscar Health from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $18.00 price target on the stock in a research report on Thursday, February 12th. Wall Street Zen lowered shares of Oscar Health from a &#34;strong-buy&#34; rating to a &#34;buy&#34; rating in a research report on Saturday. Wells Fargo &amp; Company set a $20.00 price target on shares of Oscar Health and gave the company an &#34;equal weight&#34; rating in a research report on Thursday. Finally, UBS Group lifted their price target on shares of Oscar Health from $15.00 to $20.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of &#34;Hold&#34; and a consensus target price of $20.22.</p>
<div class="lb-trans"><p>幾家研究公司最近對 OSCR 發表了評論。Zacks Research 在 5 月 7 日的研究報告中將 Oscar Health 的股票評級從 “持有” 上調至 “強力買入”。Raymond James Financial 在 2 月 12 日的研究報告中將 Oscar Health 的股票評級從 “市場表現” 上調至 “跑贏大盤”，並設定了 18.00 美元的目標價。Wall Street Zen 在一份研究報告中將 Oscar Health 的股票評級從 “強力買入” 下調至 “買入”。富國銀行在一份研究報告中設定了 Oscar Health 的目標價為 20.00 美元，並給予該公司 “等權重” 評級。最後，瑞銀集團在 5 月 7 日的研究報告中將 Oscar Health 的目標價從 15.00 美元上調至 20.00 美元，並給予該公司 “中性” 評級。一位投資分析師對該股票給予了強力買入評級，兩位給予了買入評級，八位給予了持有評級，一位給予了賣出評級。根據 MarketBeat 的數據，該股票的平均評級為 “持有”，共識目標價為 20.22 美元。</p>
</div><p><strong>Check Out Our Latest Stock Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 OSCR 股票報告</strong></p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other Oscar Health news, insider Adam Mcananey sold 9,859 shares of the business's stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $216,306.46. Following the completion of the transaction, the insider owned 218,096 shares in the company, valued at $4,785,026.24. The trade was a 4.32% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the business's stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $748,592.80. Following the completion of the transaction, the director owned 480,866 shares of the company's stock, valued at approximately $10,550,200.04. This trade represents a 6.63% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 189,660 shares of company stock valued at $4,283,140. Corporate insiders own 25.11% of the company's stock.</p>
<div class="lb-trans"><p>在關於 Oscar Health 的其他消息中，內部人士 Adam Mcananey 於 6 月 2 日星期二出售了 9,859 股該公司的股票。股票的平均售價為 21.94 美元，總價值為 216,306.46 美元。交易完成後，該內部人士持有 218,096 股公司的股票，價值為 4,785,026.24 美元。這筆交易使其持股減少了 4.32%。該交易已在向 SEC 提交的法律文件中披露，相關信息可在 SEC 網站上查閲。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售的目的是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。此外，董事 Mario Schlosser 於 6 月 2 日星期二出售了 34,120 股該公司的股票。股票的平均售價為 21.94 美元，總交易額為 748,592.80 美元。交易完成後，該董事持有 480,866 股公司的股票，價值約為 10,550,200.04 美元。這筆交易使其持股減少了 6.63%。該銷售的披露信息可在 SEC 文件中找到。該交易是在預先安排的 10b5-1 交易計劃下執行的。出售的目的是為了覆蓋與股權獎勵歸屬相關的税款扣繳義務。在過去一個季度中，內部人士已出售 189,660 股公司股票，價值為 4,283,140 美元。公司內部人士持有 25.11% 的公司股票。</p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.</p>
<div class="lb-trans"><p>Oscar Health 在紐約證券交易所以 OSCR 的股票代碼交易，是一家總部位於紐約的科技驅動健康保險公司。該公司由 Mario Schlosser、Joshua Kushner 和 Kevin Nazemi 於 2012 年創立，旨在簡化醫療保險覆蓋並提升會員體驗。Oscar 利用專有的數字平台來簡化計劃註冊、索賠管理和會員支持，在個人、家庭和小型團體保險市場中脱穎而出。</p>
</div><p>The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.</p>
<div class="lb-trans"><p>公司的主要產品包括根據《平價醫療法案》提供的交易所內個人和家庭醫療計劃、交易所外計劃以及醫療保險優勢產品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推薦故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>3 Stocks With Fresh Catalysts to Watch Before the July 4</li>
<li>Amprius Insiders Are Selling: Should Investors Be Worried?</li>
<li>A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus</li>
<li>A Market Rotation Toward Quality Will Benefit These 3 ETFs</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票超過 Oscar Health</li>
<li>7 月 4 日之前需要關注的 3 只新催化劑股票</li>
<li>Amprius 內部人士正在出售：投資者應該擔心嗎？</li>
<li>較弱的美元可能使這 3 只工業股票重新受到關注</li>
<li>向優質股票的市場輪動將使這 3 只 ETF 受益</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding OSCR?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oscar Health, Inc. (NYSE:OSCR - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 OSCR 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com，獲取 Oscar Health, Inc.（NYSE:OSCR - 免費報告）的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9TQ1I" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=OSCR"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Oscar Health 嗎？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Oscar Health 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Oscar Health 並不在名單上。</p>
</div><p>While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Oscar Health 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Oscar Health, Inc. $OSCR Shares Acquired by Geode Capital Management LLC

Market Beat

Oscar Health

Leverage Shares 2X Long OSCR Daily ETF

Defiance Daily Target 2x Long OSCR ETF

瑞傑金融

富國銀行

瑞銀集團

RAYMOND JAMES FINANCIAL INC 6.375%DEP SHS REP 1/40TH FXD FLTG SER B

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

Oscar Health, Inc. $OSCR 的股票被 Geode Capital Management LLC 收購